Qube Research & Technologies (QRT)
IRWD icon

Qube Research & Technologies (QRT)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.58M Sell
1,590,081
-91,148
-5% -$374K 0.01% 1590
2025
Q4 		$5.67M Sell
1,681,229
-1,125,681
-40% -$2.92M 0.01% 1690
2025
Q3 		$3.68M Sell
2,806,910
-544,092
-16% -$563K ﹤0.01% 1932
2025
Q2 		$2.4M Buy
3,351,002
+43,943
+1% +$34.5K ﹤0.01% 2125
2025
Q1 		$4.86M Buy
3,307,059
+3,049,329
+1,183% +$7.26M 0.01% 1555
2024
Q4 		$1.14M Sell
257,730
-313,045
-55% -$1.27M ﹤0.01% 2117
2024
Q3 		$2.35M Buy
+570,775
New +$3.07M ﹤0.01% 1703
2024
Q1 		– Sell
-79,168
Closed -$906K – 4671
2023
Q4 		$906K Buy
+79,168
New +$783K ﹤0.01% 1982
2023
Q3 		– Sell
-258,308
Closed -$2.75M – 4209
2023
Q2 		$2.75M Buy
258,308
+52,000
+25% +$559K 0.01% 917
2023
Q1 		$2.17M Buy
206,308
+36,014
+21% +$403K 0.01% 977
2022
Q4 		$2.11M Buy
170,294
+36,763
+28% +$417K 0.01% 933
2022
Q3 		$1.38M Sell
133,531
-13,494
-9% -$153K 0.01% 1077
2022
Q2 		$1.7M Buy
147,025
+90,885
+162% +$1.07M 0.01% 881
2022
Q1 		$706K Sell
56,140
-100,655
-64% -$1.15M 0.01% 1356
2021
Q4 		$1.83M Buy
156,795
+88,294
+129% +$1.08M 0.01% 884
2021
Q3 		$895K Buy
+68,501
New +$885K 0.01% 948
2021
Q1 		– Sell
-69,532
Closed -$792K – 2155
2020
Q4 		$792K Buy
+69,532
New +$761K 0.01% 951
2020
Q3 		– Sell
-54,505
Closed -$562K – 1892
2020
Q2 		$562K Buy
54,505
+38,311
+237% +$392K 0.01% 1069
2020
Q1 		$163K Buy
16,194
+3,931
+32% +$46.2K 0.01% 907
2019
Q4 		$163K Buy
+12,263
New +$135K 0.01% 1424

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Qube Research & Technologies (QRT)'s IRWD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Ironwood Pharmaceuticals (IRWD) stake by 5.4% in Q1 2026, selling an estimated $374K and leaving 1,590,081 shares worth $5.58M. The position accounts for 0.01% of the portfolio, ranked #1590.

Qube Research & Technologies (QRT) first reported a position in IRWD in Q4 2019 and has held it in 20 quarters since. The position peaked at $5.67M in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Qube Research & Technologies (QRT) held 1,590,081 shares of Ironwood Pharmaceuticals worth $5.58M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 91,148 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $374K.
  • Ironwood Pharmaceuticals made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1590 holding.
  • Qube Research & Technologies (QRT) first reported a position in Ironwood Pharmaceuticals in Q4 2019 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s Ironwood Pharmaceuticals position peaked at $5.67M in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.